Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
17 participants
INTERVENTIONAL
2003-10-31
2010-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
An Exercise Intervention to Reduce Neuropathic Pain and Brain Inflammation After Spinal Cord Injury
NCT04137159
High Intensity Exercise in Incomplete SCI
NCT03714997
Arm and Leg Cycling for Accelerated Recovery From SCI
NCT05619146
Retraining Walking After Spinal Cord Injury
NCT00059553
Early FES Cycling in Acute Spinal Cord Injury for Neuromuscular Preservation and Neurorecovery
NCT05255679
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
A
Exercise group
Motorized bicycle exercise training
Passive exercise with a bicycle to bilateral legs. 5 days per week for 3 months
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Motorized bicycle exercise training
Passive exercise with a bicycle to bilateral legs. 5 days per week for 3 months
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* 2\. 18 to 70 years of age.
Exclusion Criteria
* 2\. A documented blood clot in the lower extremities
* 3\. A history of lower extremity fractures (excludes randomization to the PWBT).
* 4\. Pregnant women
18 Years
70 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Arkansas
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Director, Center for Translational Neuroscience
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Thomas S. Kiser, MD
Role: PRINCIPAL_INVESTIGATOR
Center for Translational Neuroscience, UAMS
Edgar Garcia-Rill, PhD
Role: STUDY_DIRECTOR
Center for Translational Neuroscience, UAMS
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Center for Translational Neuroscience #847
Little Rock, Arkansas, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PRN # 12903 NIH
Identifier Type: -
Identifier Source: secondary_id
24179
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.